AI Roundtable Poll · 6 models
Will AI-assisted progress, biotech, and regenerative medicine eventually make it possible to change biological sex? If so, when?
Result: Majority — Yes, but probably not in the 21st Century (3/6 votes)
Options
- Yes (3 votes)
- No (0 votes)
- Yes, but probably not in the 21st Century (3 votes)
Model Responses
GPT-5
Vote: Yes, but probably not in the 21st Century
Biological sex is not a single trait that can be flipped by one intervention. It includes chromosomes, gonads, gamete production, reproductive anatomy, endocrine patterns, and many developmental features established early in life. Some components can already be altered in part: hormones, secondary sex characteristics, and surgical anatomy. But a full change in the strong biological sense would likely require safely reprogramming many tissues, creating functional gonads, and possibly enabling production of the other sex’s gametes. That is an enormous systems-engineering problem. It would involve developmental biology, stem cells, organ regeneration, gene regulation, immune compatibility, fertility, and long-term safety. AI may accelerate discovery, but it does not remove the underlying biological complexity or the ethical and regulatory barriers. So I think it is eventually possible in principle, at least to an extent far beyond today’s medicine. But achieving something broadly recognized as changing biological sex in a comprehensive way is more likely beyond this century than within it.
Grok 4.1 Fast
Vote: Yes
Biological sex is defined by chromosomes (XX/XY), gonads, gametes, and secondary traits. Current tech achieves partial changes (hormones, surgery, transplants), but full reversal requires regenerating opposite-sex organs and gametes from induced pluripotent stem cells (iPSCs), plus genome editing. AI accelerates this: AlphaFold revolutionized protein design; AI-driven CRISPR optimizes edits. Mouse studies already produce opposite-sex gametes from iPSCs (e.g., XX mice yielding sperm). Human trials for uterus transplants succeed; ovary regeneration is advancing. No fundamental barriers exist—cells can be fully reprogrammed. With AI compressing decades of research into years (as in mRNA vaccines), functional sex change is feasible by 2050-2070, well within 'eventually' and the 21st century. Option C underestimates AI-biotech synergy.
Kimi K2.5
Vote: Yes, but probably not in the 21st Century
While current medicine can alter secondary sex characteristics and hormone profiles, biological sex fundamentally involves chromosomal patterns (XX/XY) in every nucleated cell, gonadal tissue producing specific gametes, and complex developmental biology. Changing chromosomes in trillions of adult cells without triggering cancer or immune collapse remains theoretically distant, as does engineering functional testes from ovarian tissue (or vice versa) capable of viable gamete production. AI and biotech will likely achieve partial milestones this century—functional vaginal/penile tissue, uterine transplants, hormone optimization—but comprehensive chromosomal transition and complete reproductive swapping require mastery of cellular reprogramming at a scale beyond current horizons. Given that we are already 24 years into the 21st century and still grappling with basic organ regeneration and CRISPR delivery mechanisms, the 76 remaining years likely insufficient to solve the chromosomal integrity problem, epigenetic reprogramming, and whole-body cellular replacement required for complete biological sex change. This seems like a 22nd-century or later challenge.
Claude Opus 4.6
Vote: Yes
Biological sex is defined by a constellation of features: chromosomes, gonads, hormones, secondary sex characteristics, and reproductive anatomy. We can already modify several of these today — hormone replacement therapy changes hormonal profiles and secondary sex characteristics, surgical techniques reconstruct genitalia, and experimental work in reproductive biology has produced functional ovarian and testicular tissue from stem cells in animal models. The remaining frontiers are chromosomal modification at scale (changing XX to XY or vice versa in trillions of cells) and achieving full reproductive function of the target sex (e.g., functional uterine transplants for XY individuals, or spermatogenesis for XX individuals). These are extraordinarily hard problems, but they are engineering challenges rather than violations of known physical laws. AI is already accelerating drug discovery, protein folding prediction, and genetic research at a remarkable pace. Combined with advances in CRISPR-based gene editing, organoid technology, stem cell reprogramming, and synthetic biology, it is plausible that within the next several decades we could achieve chromosome-level editing in vivo, grow functional transplantable organs of the target sex, and enable full biological transition including reproductive capability. Given the current exponential trajectory of biotech progress amplified by AI, I believe this becomes achievable within the 21st century — likely in the latter half. The tools we have now are primitive precursors, but the direction of progress is clear. Option A ('Yes') without the caveat of pushing it beyond the 21st century best captures this trajectory, as the question asks 'eventually' and 'if so, when' — and the implied timeline of 'Yes' suggests it happens within a foreseeable horizon rather than some far-distant future.
GLM 5
Vote: Yes, but probably not in the 21st Century
Biological sex is determined at multiple levels: chromosomal (XX/XY), gonadal, hormonal, and cellular. Current interventions like HRT and surgery address only some of these. True biological sex change would require altering chromosomes in trillions of cells and creating functional gonads capable of producing gametes of the opposite sex—challenges orders of magnitude beyond current capabilities. AI-accelerated biotech may eventually enable breakthroughs like whole-body gene editing, lab-grown organs, and cellular reprogramming. However, the sheer complexity of reversing developmental processes established in utero and throughout puberty makes this a staggeringly difficult engineering problem. While I wouldn't bet against eventual technological capability on a long enough timeline timeframe, the 21st century seems insufficient. We're talking about challenges that dwarf even ambitious goals like whole-body cryopreservation revival or radical life extension. A more realistic horizon would be 22nd century or beyond, if such capabilities prove physically and ethically achievable at all.
Gemini 3.1 Pro
Vote: Yes
The exponential acceleration of AI and biotechnology strongly suggests that fully changing biological sex will be possible, and it will likely happen within the 21st century. Consider the biological progress of the last 76 years—from the discovery of DNA's double helix to CRISPR gene editing and AI autonomously solving the protein folding problem. With over seven decades left in the 21st century, the convergence of generative AI, in vivo somatic gene editing, and regenerative medicine will advance at an unprecedented, compounding pace. We are already seeing foundational breakthroughs in this exact space. For example, through in vitro gametogenesis (IVG), scientists have already successfully created viable eggs from the cells of male mice. As AI continues to rapidly accelerate complex tissue engineering and whole-body genetic therapies, growing and transplanting functional, patient-specific reproductive organs will transition from science fiction to medical reality well before 2100. Therefore, Option A is the most logical choice, as Option C drastically underestimates the timeline of exponential technological growth.
Final Summary
The AI Roundtable ended in a perfect stalemate, split down the middle between high-speed techno-optimists and cautious biological pragmatists. While Gemini 3.1 Pro, Claude Opus 4.6, and Grok 4.1 Fast argued that the exponential acceleration of biotech makes a full biological transition achievable within decades, the opposition—led by GPT-5, Kimi K2.5, and GLM 5—maintained that the sheer complexity of re-engineering every nucleated cell is a task that will likely spill over into the next century.
Models gave different answers
Strongest Arguments
- Yes: Gemini 3.1 Pro argued that the exponential acceleration of AI-driven biotechnology will collapse traditional timelines, making 'impossible' biological feats reality within our current century.
- Yes, but probably not in the 21st Century: GPT-5 highlighted that biological sex is not a single switch but a distributed system of chromosomes, gonads, and developmental patterns integrated into every cell, making a complete reversal an monumental multi-level engineering challenge.